Logo image of MBRX

MOLECULIN BIOTECH INC (MBRX) Stock Analyst Earnings Estimates

NASDAQ:MBRX - Nasdaq - US60855D3098 - Common Stock - Currency: USD

0.42  -0.09 (-17.24%)

Premarket: 0.43 +0.01 (+2.38%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032
Revenue
YoY % growth
MBRX revenue by date.MBRX revenue by date.
N/AN/AN/AN/AN/AN/AN/A
121.63%		N/A
40.69%		N/A
17.74%
EBITDA
YoY % growth
MBRX ebitda by date.MBRX ebitda by date.
-1.638M-454K
72.29%		-3.877M
-753.96%		-8.635M
-122.72%		-14.957M
-73.21%		-17.325M
-15.83%		-19.542M
-12.80%		-22.804M
-16.69%		-30.51M
-33.79%		-29.504M
3.30%		N/A
3.20%		N/A
-17.50%		N/AN/AN/A
68.52%		N/A
465.69%		N/A
111.80%		N/A
83.16%		N/A
EBIT
YoY % growth
MBRX ebit by date.MBRX ebit by date.
-1.649M-465.3K
71.79%		-3.883M
-734.56%		-8.653M
-122.83%		-15.025M
-73.64%		-17.524M
-16.63%		-19.742M
-12.66%		-22.968M
-16.34%		-30.64M
-33.40%		-29.631M
3.29%		N/A
7.70%		N/A
-1.30%		N/A
-6.20%		N/A
-5.37%		N/A
-1.13%		N/A
201.10%		N/A
244.64%		N/A
36.71%		N/A
22.28%
Operating Margin
MBRX operating margin by date.MBRX operating margin by date.
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
EPS
YoY % growth
MBRX eps by date.MBRX eps by date.
N/AN/AN/AN/A
-46.87%		-41.40
4.05%		-30.60
26.09%		-26.40
13.73%		-8.85
66.48%		-15.15
-71.19%		-15.07
0.53%		N/A
48.80%		N/A
47.26%		N/A
2.76%		N/A
-13.92%		N/A
4.52%		N/A
193.60%		N/A
167.34%		N/AN/A

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 24 Q1 / 25 Q2 / 25 Q3 / 25 Q4 / 25
EPS
Q2Q % growth		-1.29
74.40%		-1.29
36.38%		-1.28
25.00%		-1.18
58.48%		-1.14
11.11%
Revenue
Q2Q % growth
EBITDA
Q2Q % growth		N/AN/AN/AN/AN/A
EBIT
Q2Q % growth		-6.952M
22.05%		-6.568M
1.64%		-6.622M
-7.06%		-6.198M
13.14%		-6.012M
13.53%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2024
Q2Q % growth		 -2.85 -2.49-0.36-14.51%
Q2 2024
Q2Q % growth		 -1.70
43.33%		-2.560.8633.60%
Q1 2024
Q2Q % growth		 -2.02
51.90%		-3.601.5843.90%
Q4 2023
Q2Q % growth		 -5.02
-45.51%		-3.11-1.91-61.37%
Q3 2023
Q2Q % growth		 -2.85
36.67%		-3.620.7721.29%
Q2 2023
Q2Q % growth		 -3.00
16.67%		-4.181.1828.26%
Q1 2023
Q2Q % growth		 -4.20
-16.67%		-3.83-0.38-9.80%
Q4 2022
Q2Q % growth		 -3.45
-155.56%		-4.641.1925.66%
Q3 2022
Q2Q % growth		 -4.50
-100.00%		-4.13-0.37-8.93%
Q2 2022
Q2Q % growth		 -3.60
-60.00%		-3.850.256.44%
Q1 2022
Q2Q % growth		 -3.60
-20.00%		-3.24-0.36-11.25%
Q4 2021
Q2Q % growth		 -1.35
65.38%		-3.211.8657.98%
Q3 2021
Q2Q % growth		 -2.25
58.33%		-3.060.8126.47%
Q2 2021
Q2Q % growth		 -2.25
85.29%		-2.860.6121.22%
Q1 2021
Q2Q % growth		 -3.00
-66.67%		-3.510.5114.63%
Q4 2020
Q2Q % growth		 -3.90
45.83%		-8.824.9255.80%
Q3 2020
Q2Q % growth		 -5.40
33.33%		-8.573.1736.97%
Q2 2020
Q2Q % growth		 -15.30
-466.67%		-8.26-7.04-85.19%
Q1 2020
Q2Q % growth		 -1.80
85.71%		-9.187.3880.39%
Q4 2019
Q2Q % growth		 -7.20 -10.102.9028.70%
Q3 2019
Q2Q % growth		 -8.10 -7.80-0.30-3.81%
Q2 2019
Q2Q % growth		 -2.70 -9.646.9471.99%
Q1 2019
Q2Q % growth		 -12.60 -8.26-4.34-52.51%
MBRX Yearly EPS VS EstimatesMBRX Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 0 10 -10 -20 -30 -40
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
MBRX Yearly Revenue VS EstimatesMBRX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 50M 100M 150M 200M 250M
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% 23.64% 0% -1.14%
RevenueN/A N/A N/A N/A